Cargando…
Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306195/ https://www.ncbi.nlm.nih.gov/pubmed/32579985 http://dx.doi.org/10.1016/j.jinf.2020.06.006 |
| _version_ | 1783548608046432256 |
|---|---|
| author | M, Montero-Baladía L, Buzón I, Astigarraga P, Delgado E, Iglesias F, Callejo M, López-Veloso J, Minguito M, Fernández-Regueras M, Ubeira G, Hermida |
| author_facet | M, Montero-Baladía L, Buzón I, Astigarraga P, Delgado E, Iglesias F, Callejo M, López-Veloso J, Minguito M, Fernández-Regueras M, Ubeira G, Hermida |
| author_sort | M, Montero-Baladía |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7306195 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73061952020-06-22 Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients M, Montero-Baladía L, Buzón I, Astigarraga P, Delgado E, Iglesias F, Callejo M, López-Veloso J, Minguito M, Fernández-Regueras M, Ubeira G, Hermida J Infect Article The British Infection Association. Published by Elsevier Ltd. 2020-09 2020-06-21 /pmc/articles/PMC7306195/ /pubmed/32579985 http://dx.doi.org/10.1016/j.jinf.2020.06.006 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article M, Montero-Baladía L, Buzón I, Astigarraga P, Delgado E, Iglesias F, Callejo M, López-Veloso J, Minguito M, Fernández-Regueras M, Ubeira G, Hermida Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients |
| title | Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients |
| title_full | Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients |
| title_fullStr | Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients |
| title_full_unstemmed | Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients |
| title_short | Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients |
| title_sort | etoposide treatment adjunctive to immunosuppressants for critically ill covid-19 patients |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306195/ https://www.ncbi.nlm.nih.gov/pubmed/32579985 http://dx.doi.org/10.1016/j.jinf.2020.06.006 |
| work_keys_str_mv | AT mmonterobaladia etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT lbuzon etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT iastigarraga etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT pdelgado etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT eiglesias etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT fcallejo etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT mlopezveloso etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT jminguito etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT mfernandezregueras etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT mubeira etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients AT ghermida etoposidetreatmentadjunctivetoimmunosuppressantsforcriticallyillcovid19patients |